Label-free quantitative proteomics reveals aberrant expression levels of LRG, C9, FN, A1AT and AGP1 in the plasma of patients with colorectal cancer

20 Sep 2023
0
0

Label-free quantitative proteomics reveals aberrant expression levels of LRG, C9, FN, A1AT and AGP1 in the plasma of patients with colorectal cancer

Verathamjamras C, Chantaraamporn J, Sornprachum T, Mutapat P, Chokchaichamnankit D, Mingkwan K, Luevisadpibul V, Srisomsap C, Chutipongtanate S, Svasti J, Champattanachai V

Clin Proteomics. 2023;20(1):15.

Tags

Share this

Related Posts

Molecular dynamics, MM/PBSA and in vitro validation of a novel quinazoline-based EGFR tyrosine kinase inhibitor identified using structure-based in silico screening. Ornnork N, Kiriwan D, Lirdprapamongkol K, Choowongkomon K, Svasti J, Eurtivong C*. J Mol Graph Model. 2020 Sep;99:107639.
01 Sep 2020
0

Molecular dynamics, MM/PBSA and in vitro validation of a novel quinazoline-based EGFR tyrosine kinase inhibitor identified using structure-based in silico screening. Ornnork N, Kiriwan D, Lirdprapamongkol K, Choowongkomon K, Svasti J, Eurtivong C*. J Mol Graph Model. 2020 Sep;99:107639.

Molecular dynamics, MM/PBSA and in vitro validation of a novel quinazoline-based EGFR tyrosine kinase inhibitor identified using structure-based in silico screening. Ornnork N, Kiriwan D, Lirdprapamongkol K, Choowongkomon K, Svasti J, Eurtivong C*. J Mol Graph Model. 2020 Sep;99:107639.
View More

Recent Posts